🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
BEYOND represents an open-label, parallel, three-arm randomized controlled ...
Status
Completed
Location
Unit of Endocrinology and Metabolic Diseases
Start Date
2019-11-27
Trial ID
NCT04196231
Treatments Being Tested
This study will investigate the utility of a polypill-based strategy for pa...
Status
Recruiting
Location
UT Southwestern Medical Center
Start Date
2024-03-11
Trial ID
NCT06143566
Treatments Being Tested
Diabetes is the leading cause of chronic kidney disease (CKD) and end-stage...
Status
Unknown
Location
Multiple Locations
Start Date
2023-03
Trial ID
NCT05373004
Treatments Being Tested
The objective of the current study is to investigate the efficacy, safety a...
Status
Completed
Location
1245.10.10026 Boehringer Ingelheim Investigational Site
Start Date
2008-08
Trial ID
NCT00749190
Treatments Being Tested
This is a single center, single arm, prospective, 12 week open label pilot ...
Status
Completed
Location
Columbia University Irving Medical Center / NewYork-Presbyterian Hospital
Start Date
2022-03-14
Trial ID
NCT05233163
Treatments Being Tested
CREST-KT is a single-center, double-blinded, randomized trial of empagliflo...
Status
Terminated
Location
Duke University Medical Center
Start Date
2022-07-25
Trial ID
NCT04906213
Treatments Being Tested
Non-Alcoholic Fatty Liver Disease( NAFLD) is common in patients with type 2...
Status
Unknown
Location
University of Malaya
Start Date
2016-11
Trial ID
NCT02964715
Treatments Being Tested
A multicenter, open-label, single-arm study with regard to the efficacy and...
Status
Unknown
Location
Kobe University Hospital
Start Date
2019-09-01
Trial ID
NCT04018365
Treatments Being Tested
SAVE-Care (Sodium Glucose Cotransporter-2 inhibitors \[SGLT2i\] As Novel Go...
Status
Recruiting
Location
Massachusetts General Hospital
Start Date
2026-07-01
Trial ID
NCT06674109
Treatments Being Tested
The goal of this clinical trial is to learn if Empagliflozin and Semaglutid...
Status
Recruiting
Location
Research Institute of the McGill University Health Centre
Start Date
2025-04
Trial ID
NCT06894784